Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08WGZ
|
||||
| Former ID |
DIB010597
|
||||
| Drug Name |
TS-033
|
||||
| Synonyms |
SGL-0010; SGLT-2 inhibitor (diabetes), Taisho; Sodium-dependent glucose transporter-2 inhibitor (diabetes), Taisho
|
||||
| Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 2 | [548084] | ||
| Company |
Taisho Pharmaceutical Co Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | SLGT2 | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.